{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:17:52Z","timestamp":1740143872570,"version":"3.37.3"},"reference-count":53,"publisher":"Zhejiang University Press","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1631\/jzus.b2200054","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T03:02:37Z","timestamp":1668999757000},"page":"899-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study","\u65b0\u51a0\u75ab\u82d7\u5bf9SARS-CoV-2 Delta\u611f\u67d3\u8005\u4e34\u5e8a\u75c7\u72b6\u548c\u514d\u75ab\u5e94\u7b54\u53cd\u5e94\u7684\u5f71\u54cd:\u4e00\u9879\u56de\u987e\u6027\u7814\u7a76"],"prefix":"10.1631","volume":"23","author":[{"given":"Cunjin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luojing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-0012","authenticated-orcid":false,"given":"Yusheng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-7574","authenticated-orcid":false,"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"2","key":"647_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2104974","volume":"385","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad LJ, Chemaitelly H, Butt AA, et al., 2021. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. N Engl J Med, 385(2): 187\u2013189. https:\/\/doi.org\/10.1056\/NEJMc2104974","journal-title":"N Engl J Med"},{"issue":"5","key":"647_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, el Sahly HM, Essink B, et al., 2021. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med, 384(5):403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"issue":"1","key":"647_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1080\/22221751.2021.1994356","volume":"10","author":"A Baj","year":"2021","unstructured":"Baj A, Novazzi F, Ferrante FD, et al., 2021. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy. Emerg Microbes Infect, 10(1):2010\u20132015. https:\/\/doi.org\/10.1080\/22221751.2021.1994356","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"647_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4149\/av_2020_203","volume":"64","author":"K Be\u0148ov\u00e1","year":"2020","unstructured":"Be\u0148ov\u00e1 K, Hanckov\u00e1 M, Ko\u010di K, et al., 2020. T cells and their function in the immune response to viruses. Acta Virol, 64(2):131\u2013143. https:\/\/doi.org\/10.4149\/av_2020_203","journal-title":"Acta Virol"},{"issue":"3","key":"647_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3760\/cma.j.issn.1001-0939.2020.03.013","volume":"43","author":"L Chen","year":"2020","unstructured":"Chen L, Liu HG, Liu W, et al., 2020. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Chin J Tuberc Respir Dis, 43(3):203\u2013208 (in Chinese). https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2020.03.013","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"6570","key":"647_CR6","doi-asserted-by":"publisher","first-page":"eabj9932","DOI":"10.1126\/science.abj9932","volume":"374","author":"MS Dhar","year":"2021","unstructured":"Dhar MS, Marwal R, Vs R, et al., 2021. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science, 374(6570):eabj9932. https:\/\/doi.org\/10.1126\/science.abj9932","journal-title":"Science"},{"issue":"7","key":"647_CR7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","volume":"46","author":"P Gabarre","year":"2020","unstructured":"Gabarre P, Dumas G, Dupont T, et al., 2020. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med, 46(7):1339\u20131348. https:\/\/doi.org\/10.1007\/s00134-020-06153-9","journal-title":"Intensive Care Med"},{"issue":"11","key":"647_CR8","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/v13112310","volume":"13","author":"AK Ghosh","year":"2021","unstructured":"Ghosh AK, Kaiser M, Molla MA, et al., 2021. Molecular and serological characterization of the SARS-CoV-2 delta variant in Bangladesh in 2021. Viruses, 13(11):2310. https:\/\/doi.org\/10.3390\/v13112310","journal-title":"Viruses"},{"issue":"9","key":"647_CR9","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","volume":"85","author":"I Glowacka","year":"2011","unstructured":"Glowacka I, Bertram S, Muller MA, et al., 2011. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol, 85(9):4122\u20134134. https:\/\/doi.org\/10.1128\/JVI.02232-10","journal-title":"J Virol"},{"key":"647_CR10","doi-asserted-by":"publisher","unstructured":"Gupta N, Kaur H, Yadav PD, et al., 2021. Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of India. Viruses, 13(9):1782. https:\/\/doi.org\/10.3390\/v13091782","DOI":"10.3390\/v13091782"},{"issue":"2","key":"647_CR11","first-page":"212","volume":"31","author":"A Haileamlak","year":"2021","unstructured":"Haileamlak A, 2021. After a year, SARS-CoV-2 is not well known. Ethiop J Health Sci, 31(2):212.","journal-title":"Ethiop J Health Sci"},{"issue":"10286","key":"647_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","volume":"397","author":"VJ Hall","year":"2021","unstructured":"Hall VJ, Foulkes S, Saei A, et al., 2021. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet, 397(10286):1725\u20131735. https:\/\/doi.org\/10.1016\/S0140-6736(21)00790-X","journal-title":"Lancet"},{"issue":"2","key":"647_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, et al., 2004. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol, 203(2):631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"J Pathol"},{"issue":"7","key":"647_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/jim-2020-001407","volume":"68","author":"P Hansrivijit","year":"2020","unstructured":"Hansrivijit P, Qian CC, Boonpheng B, et al., 2020. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. J Investig Med, 68(7):1261\u20131270. https:\/\/doi.org\/10.1136\/jim-2020-001407","journal-title":"J Investig Med"},{"issue":"2","key":"647_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al., 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2):271\u2013280.E8. https:\/\/doi.org\/10.1016\/j-cell.2020.02.052","journal-title":"Cell"},{"issue":"2","key":"647_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.21037\/qims.2020.02.10","volume":"10","author":"XF Hu","year":"2020","unstructured":"Hu XF, Chen JF, Jiang XM, et al., 2020. CT imaging of two cases of one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: inconsistency between clinical symptoms amelioration and imaging sign progression. Quant Imaging Med Surg, 10(2):508\u2013510. https:\/\/doi.org\/10.21037\/qims.2020.02.10","journal-title":"Quant Imaging Med Surg"},{"issue":"10223","key":"647_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"CL Huang","year":"2020","unstructured":"Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"647_CR18","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-021-24285-4","volume":"12","author":"P Jalkanen","year":"2021","unstructured":"Jalkanen P, Kolehmainen P, H\u00e4kkinen HK, et al., 2021. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun, 12:3991. https:\/\/doi.org\/10.1038\/s41467-021-24285-4","journal-title":"Nat Commun"},{"key":"647_CR19","doi-asserted-by":"publisher","unstructured":"Kemp SA, Collier DA, Datir R, et al., 2020. Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation. medRxiv, preprint. https:\/\/doi.org\/10.1101\/2020.12.05.20241927","DOI":"10.1101\/2020.12.05.20241927"},{"key":"647_CR20","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1038\/s41598-018-34859-w","volume":"8","author":"H Kleine-Weber","year":"2018","unstructured":"Kleine-Weber H, Elzayat MT, Hoffmann M, et al., 2018. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Sci Rep, 8:16597. https:\/\/doi.org\/10.1038\/s41598-018-34859-w","journal-title":"Sci Rep"},{"issue":"1","key":"647_CR21","doi-asserted-by":"publisher","first-page":"e200028","DOI":"10.1148\/ryct.2020200028","volume":"2","author":"WF Kong","year":"2020","unstructured":"Kong WF, Agarwal PP, 2020. Chest imaging appearance of COVID-19 infection. Radiol Cardiothorac Imaging, 2(1): e200028. https:\/\/doi.org\/10.1148\/ryct.2020200028","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"1","key":"647_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1148\/radiol.2020200236","volume":"295","author":"JQ Lei","year":"2020","unstructured":"Lei JQ, Li JF, Li X, et al., 2020. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 295(1): 18. https:\/\/doi.org\/10.1148\/radiol.2020200236","journal-title":"Radiology"},{"key":"647_CR23","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","volume":"156","author":"RF Li","year":"2020","unstructured":"Li RF, Hou YL, Huang JC, et al., 2020. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res, 156: 104761. https:\/\/doi.org\/10.1016\/j.phrs.2020.104761","journal-title":"Pharmacol Res"},{"issue":"9","key":"647_CR24","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/jmv.25727","volume":"92","author":"ZT Li","year":"2020","unstructured":"Li ZT, Yi YX, Luo XM, et al., 2020. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol, 92(9):1518\u20131524. https:\/\/doi.org\/10.1002\/jmv.25727","journal-title":"J Med Virol"},{"key":"647_CR25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","volume":"11","author":"YW Liang","year":"2020","unstructured":"Liang YW, Wang ML, Chien CS, et al., 2020. Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-CoV-2 infection. Front Immunol, 11:1022. https:\/\/doi.org\/10.3389\/fimmu.2020.01022","journal-title":"Front Immunol"},{"issue":"15","key":"647_CR26","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1056\/NEJMc2102017","volume":"384","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu JY, Xia HJ, et al., 2021. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med, 384(15):1466\u20131468. https:\/\/doi.org\/10.1056\/NEJMc2102017","journal-title":"N Engl J Med"},{"issue":"6","key":"647_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, et al., 2020. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med, 26(6):845\u2013848. https:\/\/doi.org\/10.1038\/s41591-020-0897-1","journal-title":"Nat Med"},{"issue":"10","key":"647_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1631\/jzus.B2100151","volume":"22","author":"HH Lu","year":"2021","unstructured":"Lu HH, Shi Y, Chen KL, et al., 2021. Impact of antitumor regimens on the outcomes of cancer patients with COVID-19: a pooled analysis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(10):876\u2013884. https:\/\/doi.org\/10.1631\/jzus.B2100151","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"10224","key":"647_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"RJ Lu","year":"2020","unstructured":"Lu RJ, Zhao X, Li J, et al., 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224): 565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"key":"647_CR30","doi-asserted-by":"publisher","first-page":"111254","DOI":"10.1016\/j.biopha.2021.111254","volume":"137","author":"JA Malik","year":"2021","unstructured":"Malik JA, Mulla AH, Farooqi T, et al., 2021. Targets and strategies for vaccine development against SARS-CoV-2. Biomed Pharmacother, 137:111254. https:\/\/doi.org\/10.1016\/j.biopha.2021.111254","journal-title":"Biomed Pharmacother"},{"key":"647_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.12688\/f1000research.26186.1","volume":"9","author":"M Mudatsir","year":"2020","unstructured":"Mudatsir M, Fajar JK, Wulandari L, et al., 2020. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res, 9:1107. https:\/\/doi.org\/10.12688\/f1000research.26186.2","journal-title":"F1000Res"},{"issue":"1","key":"647_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bsheal.2020.02.001","volume":"2","author":"National Health Commission of the People\u2019s Republic of China","year":"2020","unstructured":"National Health Commission of the People\u2019s Republic of China, 2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition). Biosaf Health, 2(1):3\u20135. https:\/\/doi.org\/10.1016\/j.bsheal.2020.02.001","journal-title":"Biosaf Health"},{"key":"647_CR33","unstructured":"National Health Commission of the People\u2019s Republic of China, National Administration of Tranditional Chinese Medicine, 2022. Diagnosis and treatment protocol for COVID-19 (trial version 9). http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202203\/b74ade1ba4494583805a3d2e40093d88.shtml (in Chinese)."},{"issue":"5\u20136","key":"647_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/ijmr.ijmr_1353_21","volume":"153","author":"G Novelli","year":"2021","unstructured":"Novelli G, Colona VL, Pandolfi PP, 2021. A focus on the spread of the delta variant of SARS-CoV-2 in India. Indian J Med Res, 153(5\u20136):537\u2013541. https:\/\/doi.org\/10.4103\/ijmr.ijmr_1353_21","journal-title":"Indian J Med Res"},{"issue":"3","key":"647_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2020200370","volume":"295","author":"F Pan","year":"2020","unstructured":"Pan F, Ye TH, Sun P, et al., 2020. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology, 295(3):715\u2013721. https:\/\/doi.org\/10.1148\/radiol.2020200370","journal-title":"Radiology"},{"key":"647_CR36","doi-asserted-by":"publisher","first-page":"e933622","DOI":"10.12659\/MSM.933622","volume":"27","author":"DV Parums","year":"2021","unstructured":"Parums DV, 2021. Editorial: Revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2. Med Sci Monit, 27:e933622. https:\/\/doi.org\/10.12659\/MSM.933622","journal-title":"Med Sci Monit"},{"issue":"4","key":"647_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"HS Shi","year":"2020","unstructured":"Shi HS, Han XY, Jiang NC, et al., 2020. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 20(4): 425\u2013434. https:\/\/doi.org\/10.1016\/S1473-3099(20)30086-4","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"647_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1631\/jzus.B2000083","volume":"21","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang G, Cai XP, et al., 2020. An overview of COVID-19. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(5): 343\u2013360. https:\/\/doi.org\/10.1631\/jzus.B2000083","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"issue":"20","key":"647_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","volume":"384","author":"V Shinde","year":"2021","unstructured":"Shinde V, Bhikha S, Hoosain Z, et al., 2021. Efficacy of NVX-CoV2373 COVID-19 vaccine against the B.1.351 variant. N Engl J Med, 384(20):1899\u20131909. https:\/\/doi.org\/10.1056\/NEJMoa2103055","journal-title":"N Engl J Med"},{"issue":"16","key":"647_CR40","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMc2036242","volume":"384","author":"DM Skowronski","year":"2021","unstructured":"Skowronski DM, de Serres G, 2021. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med, 384(16):1576\u20131577. https:\/\/doi.org\/10.1056\/NEJMc2036242","journal-title":"N Engl J Med"},{"issue":"10","key":"647_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/14760584.2020.1825951","volume":"19","author":"J Sultana","year":"2020","unstructured":"Sultana J, Mazzaglia G, Luxi N, et al., 2020. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations. Expert Rev Vaccines, 19(10):919\u2013936. https:\/\/doi.org\/10.1080\/14760584.2020.1825951","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"647_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, et al., 2020. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost, 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"issue":"10269","key":"647_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, et al., 2021. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, 397(10269):99\u2013111. https:\/\/doi.org\/10.1016\/S0140-6736(20)32661-1","journal-title":"Lancet"},{"issue":"5","key":"647_CR44","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.1111\/sji.12873","volume":"91","author":"ZK Wan","year":"2020","unstructured":"Wan ZK, Zhou ZF, Liu Y, et al., 2020. Regulatory T cells and T helper 17 cells in viral infection. Scand J Immunol, 91(5):e12873. https:\/\/doi.org\/10.1111\/sji.12873","journal-title":"Scand J Immunol"},{"issue":"1","key":"647_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang MM, Chen X, et al., 2020. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol, 108(1):17\u201341. https:\/\/doi.org\/10.1002\/JLB.3COVR0520-272R","journal-title":"J Leukoc Biol"},{"issue":"3","key":"647_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.thromres.2010.11.032","volume":"127","author":"ZF Wang","year":"2011","unstructured":"Wang ZF, Su F, Lin XJ, et al., 2011. Serum D-dimer changes and prognostic implication in 2009 novel influenza A (H1N1). Thromb Res, 127(3):198\u2013201. https:\/\/doi.org\/10.1016\/j.thromres.2010.11.032","journal-title":"Thromb Res"},{"key":"647_CR47","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3389\/fimmu.2018.02093","volume":"9","author":"XJ Wu","year":"2018","unstructured":"Wu XJ, Wu P, Shen YF, et al., 2018. CD8+ resident memory T cells and viral infection. Front Immunol, 9:2093. https:\/\/doi.org\/10.3389\/fimmu.2018.02093","journal-title":"Front Immunol"},{"issue":"13","key":"647_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"ZY Wu","year":"2020","unstructured":"Wu ZY, McGoogan JM, 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323(13):1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","journal-title":"JAMA"},{"issue":"1","key":"647_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","volume":"9","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Liu Y, Cao L, et al., 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect, 9(1):761\u2013770. https:\/\/doi.org\/10.1080\/22221751.2020.1747363","journal-title":"Emerg Microbes Infect"},{"issue":"8","key":"647_CR50","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","volume":"26","author":"X Xu","year":"2020","unstructured":"Xu X, Sun J, Nie S, et al., 2020. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med, 26(8):1193\u20131195. https:\/\/doi.org\/10.1038\/s41591-020-0949-6","journal-title":"Nat Med"},{"issue":"3","key":"647_CR51","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"XT Xu","year":"2020","unstructured":"Xu XT, Chen P, Wang JF, et al., 2020. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 63(3):457\u2013460. https:\/\/doi.org\/10.1007\/s11427-020-1637-5","journal-title":"Sci China Life Sci"},{"issue":"2","key":"647_CR52","doi-asserted-by":"publisher","first-page":"e21245","DOI":"10.1096\/fj.202002512","volume":"35","author":"SM Yan","year":"2021","unstructured":"Yan SM, Wu G, 2021. Is lymphopenia different between SARS and COVID-19 patients? FASEB J, 35(2):e21245. https:\/\/doi.org\/10.1096\/fj.202002512","journal-title":"FASEB J"},{"key":"647_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-020-01338-8","volume":"21","author":"GM Zhang","year":"2020","unstructured":"Zhang GM, Zhang J, Wang BW, et al., 2020. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res, 21:74. https:\/\/doi.org\/10.1186\/s12931-020-01338-8","journal-title":"Respir Res"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2200054\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T09:05:59Z","timestamp":1669021559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2200054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2200054","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"type":"print","value":"1673-1581"},{"type":"electronic","value":"1862-1783"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}